No absolute contraindication.

Casirivimab and imdevimab combination is not authorized for use in patients with any of the following:

- Age < 12 years and weight < 40 kg

- Hospitalized due to COVID-19

- Requiring oxygen support

- Patients with underlying non-COVID-19 related comorbidities already on oxygen therapy who have an increase in baseline oxygen requirement from COVID-19